| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 54.846 | 54.594 | 53.687 | 50.305 | 28.671 | 15.726 | 32.141 | 56.182 | 47.922 | 35.859 |
| Total Income - EUR | 55.159 | 54.636 | 53.692 | 50.309 | 28.672 | 39.741 | 32.141 | 56.182 | 47.926 | 35.951 |
| Total Expenses - EUR | 47.528 | 37.125 | 65.639 | 69.154 | 53.639 | 37.463 | 77.541 | 48.796 | 51.951 | 38.310 |
| Gross Profit/Loss - EUR | 7.631 | 17.511 | -11.947 | -18.845 | -24.967 | 2.278 | -45.401 | 7.386 | -4.025 | -2.359 |
| Net Profit/Loss - EUR | 6.234 | 14.676 | -13.558 | -20.354 | -25.827 | 1.190 | -46.365 | 5.700 | -4.025 | -2.359 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neuromed Sistem Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 22 | 21 | 21 | 21 | 20 | 20 | 20 | 20 |
| Current Assets | 196.959 | 209.426 | 184.225 | 149.803 | 119.368 | 97.814 | 50.467 | 53.303 | 49.926 | 48.385 |
| Inventories | 52.050 | 54.118 | 48.996 | 45.503 | 45.275 | 47.970 | 30.313 | 30.407 | 25.644 | 25.501 |
| Receivables | 141.730 | 152.971 | 132.604 | 99.645 | 71.776 | 44.787 | 13.725 | 18.560 | 18.202 | 16.485 |
| Cash | 3.178 | 2.338 | 2.625 | 4.656 | 2.317 | 5.057 | 6.429 | 4.335 | 6.080 | 6.399 |
| Shareholders Funds | 31.459 | 45.815 | 31.482 | 10.550 | -15.482 | -13.998 | -60.053 | -54.539 | -58.399 | -60.431 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 165.499 | 163.611 | 152.765 | 139.274 | 134.871 | 111.833 | 110.540 | 107.862 | 108.345 | 108.836 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Neuromed Sistem Srl